Determination of Pharmacokinetics of Different Curcuminoids Preparations: Pilot Study
- Conditions
- Plasma Levels of Different Curcuminoids Preparations
- Interventions
- Dietary Supplement: Curcumin
- Registration Number
- NCT05542394
- Lead Sponsor
- University of Jordan
- Brief Summary
This pilot study aims to investigate the pharmacokinetics of a novel curcuminoid preparation with suggested high bioavailability due to its solubility in water, compared to two standard hydrophobic formulations. The findings of this study will help the health care providers and community to select suitable formulation.
- Detailed Description
This pilot study is the first phase that must be followed, in the second phase, by longer clinical trials to support the findings and investigate the role of the novel preparation on health.The second phase will include an assessment of the effectiveness of several doses of curcumin preparation on health as well as an evaluation of the tolerance and possible adverse effects. The latter could not be evaluated at this stage of a single dose.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 24
Male and female Apparently healthy adults
Postmenopausal women Smokers Overweight Chronic diseases
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Tumeric with piperine SAP Curcumin Turmeric extract standardized to 95% curcuminoids in combination with 5 mg of piperine per capsule will be administered orally (1 dose) Tumeric without piperine Curcumin Turmeric extract standardized to 95% curcuminoids without piperine will be administered orally (1 dose) Curcumin H2O SAP Curcumin Water soluble version of turmeric extract standardized to 10% curcuminoids will be administered orally (1 dose)
- Primary Outcome Measures
Name Time Method Blood concentration of piperine-curcuminoids [Time Frame: Change during 8 hours] plasma piperine-curcuminoids levels using LC MS/MS
Blood concentration of hexahydrocurcumin [Time Frame: Change during 8 hours] plasma hexahydrocurcumin levels using LC MS/MS
Blood concentration of curcumin diethyl disuccinate [Time Frame: Change during 8 hours] plasma curcumin diethyl disuccinate levels using LC MS/MS
Blood concentration of curcumin [Time Frame: Change during 8 hours] plasma curcumin levels using LC MS/MS
Blood concentration of desmethoxycurcumin [Time Frame: Change during 8 hours] plasma desmethoxycurcumin levels using LC MS/MS
Blood concentration of bisdemethoxycurcumin [Time Frame: Change during 8 hours] plasma bisdemethoxycurcumin levels using LC MS/MS
Blood concentration of tetrahydrocurcumin [Time Frame: Change during 8 hours] plasma tetrahydrocurcumin levels using LC MS/MS
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
The University of Jordan
🇯🇴Amman, Jordan